Page 169 - CW E-Magazine (28-5-2024)
P. 169

News from Abroad


       milestone not only for Asahi Kasei, but  late fluctuating power input from solar  sers in 2025. The pilot plant in Kawasaki
       also for the global hydrogen business  or wind power. By utilising the data   is an important step toward achieving
       in general. We believe that successfully   obtained from these trials, Asahi Kasei will   this goal, after the successful long-
       operating our equipment in this test   further optimise the equipment design,  term tests of its 10-MW single-stack
       facility will be a door opener for commer-  operation methods, and control techno-  alkaline-water electrolysis system at
       cial large-scale multi-module alkaline  logy of the electrolysis system.   the Fukushima Energy Research Field
       water electrolysers  and  eventually the                           (FH2R)1 in Namie, Fukushima, Japan,
       realisation of a hydrogen society.”  With its multi-module  approach,  since 2020.  The practical experience
                                         Asahi Kasei aims to combine up to ten  gained in Namie and the trial operation
          For the production of green hydro-  modules with a capacity of  10-MW  at the pilot plant in Kawasaki will
       gen, electrolysis systems need to res-  each, enabling commercial large-scale  further  underpin Asahi  Kasei’s market
       pond to fluctuating power supply from  electrolysis systems with a capacity of  entry with large-scale and highly reliable
       renewable energy sources such as wind  up to 100-MW.               multi-module alkaline water electrolysis
       or solar. In the pilot plant, four 0.8-MW                          equipment. This experience will also be
       Aqualyzer modules  are  being  opera-  Commercialisation in 2025   leveraged for the joint feasibility study
       ted under realistic conditions, including   Aiming for a total sales volume of  with Gentari and JGC for a 60 MW-class
       operation during maintenance and low  ¥100-bn (€600-mn) by 2030, the com-  electrolyser in Malaysia (GI-Phase 2)
       power supply during nighttime. In addi-  pany plans to start commercial business  targeted for 2027, as announced in
       tion, the equipment is designed to simu-  activities for its alkaline water electroly-  November 2023.

       SKIN REJUVENATION
       Beiersdorf and Rubedo announce collaboration

       in cellular senescence

          German cosmetics major, Beiersdorf,                                      validating  the effectiveness
       and  US  biopharma  firm,  Rubedo  Life                                     of the selected substances  in
       Science, have entered into a multi-                                         cosmetic skin care formula-
       year strategic partnership to develop a                                     tions.
       breakthrough  anti-aging  solutions for
       the global face care market. Rubedo                                           Beiersdorf’s  CEO Mr.
       Life Science specialises in  the deve-                                      Vincent Warnery commen-
       lopment of solutions targeting cellular                                     ted, “Our mission is to define
       senescence.                                                                 the future of skin care through
                                                                                   breakthrough innovation. By
          Beiersdorf, best known for its Nivea                                     partnering  with Rubedo and
       branded  products, additionally  joins                                      combining cutting-edge exper-
       Rubedo as strategic  investor, having                                       tise from both sides, we aim
       participated in its recently closed Series                                  to redefine the standards in
       A financing round through its Oscar &  skin  changes  and  pathologies.  These  anti-age skincare.”
       Paul Corporate Venture Capital Fund.   compounds will be sourced from Rubedo’s
                                         topical dermatology programme, which   “By combining Rubedo’s expertise
       Antiaging                         have  senolytic  and  anti-inflammatory  in cellular senescence with Beiers-
          The partnership revolves around  properties.                    dorf’s expertise in skin care innova-
       the exploration of novel compounds                                 tion, this partnership may revolutio-
       derived from Rubedo’s  research pro-  As part of this partnership, Beiersdorf   nise the landscape of skin care prod-
       grammes, specifically targeting cellular  will  conduct  in  vitro  &  in  silico   ucts, offering consumers new solutions
       senescence. Senescent cells (Latin se-  studies and conduct stringent  assess-  that treat cellular aging for healthy
       nescere = to grow old, to age) accumu-  ments of  Rubedo’s  candidate com-  and youthful-looking skin,” added
       late with age and cause inflammation,  pounds.  This collaboration will result   Mr. Marco Quarta, CEO, Rubedo Life
       which may contribute to age-related  in  in-vivo human studies, aimed at  Sciences.

       Chemical Weekly  May 28, 2024                                                                   169


                                      Contents    Index to Advertisers    Index to Products Advertised
   164   165   166   167   168   169   170   171   172   173   174